SCHEMBL27365633

SCHEMBL27365633

Cc1cc2ncc(C=O)nc2cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
NPC1 O15118 5/20 0.44
RAB9A P51151 4/20 0.44
PDGFRB P09619 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDR P35968 1/20 0.44
FLT3 P36888 1/20 0.44
PDGFRA P16234 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C19 P33261 1/20 0.41
NQO2 P16083 1/20 0.39
KDM4E B2RXH2 5/20 0.38
MAPT P10636 4/20 0.38
BACE1 P56817 1/20 0.37
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30594656 1.00 ALDH1A1 (0.52) ALDH1A1NPC1RAB9APDGFRBSMN1; SMN2
SCHEMBL12086507 0.79 ALDH1A1 (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL1401306 0.79 ALDH1A1 (0.49) ALDH1A1PDGFRBSMN1; SMN2PDGFRANQO2
SCHEMBL6187822 0.74 PAX8 (0.47) ALDH1A1NPC1RAB9APDGFRBSMN1; SMN2
SCHEMBL9798625 0.74 ALDH1A1 (0.36) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL29092402 0.73 SMN1; SMN2 (0.42) ALDH1A1NPC1RAB9APDGFRBSMN1; SMN2
SCHEMBL30594658 0.73 SMN1; SMN2 (0.42) ALDH1A1NPC1RAB9APDGFRBSMN1; SMN2
SCHEMBL10974039 0.72 CYP1A2 (0.49) ALDH1A1NPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL28946507 0.72 APP (0.46) ALDH1A1PDGFRBPDGFRACYP1A2KDM4E
SCHEMBL28964184 0.72 APP (0.46) ALDH1A1PDGFRBKDRPDGFRACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028624-A Quinoxaline framework NN oxazoline ligand and synthetic method and application thereof 上海师范大学 2022-09-09 CN claimed
CN-115028624-B Quinoxaline skeleton NN oxazoline ligand and synthetic method and application thereof 上海师范大学 2023-10-27 CN disclosed
CN-115028624-A Quinoxaline framework NN oxazoline ligand and synthetic method and application thereof 上海师范大学 2022-09-09 CN disclosed
CN-1065744-C Treatment of diseases associated with platelet derived growth factor such as cancer SUGEN INC (US) 2001-05-16 CN disclosed
CN-1128496-A Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor SUGEN INC (US) 1996-08-07 CN disclosed